Levoketoconazole Effectively Treats Endogenous Cushing Syndrome in Phase 3 Trial
According to results of the phase 3 SONICS trial, levoketoconazole is a safe and effective treatment option for patients with Cushing syndrome.
Cushing Syndrome
Sex Affects Clinical Presentation of ACTH-Dependent Cushing Syndrome
Researchers examined sex differences in clinical presentation and patient outcomes in ACTH-dependent Cushing syndrome.
Signs and Symptoms of Adrenal Medullary Hyperplasia vs Pheochromocytoma
Patients with AMH without pheochromocytoma had milder symptoms compared with patients with pheochromocytoma only.
Mifepristone an Effective Alternative to Surgery for Patients With Bilateral Macronodular Adrenal Hyperplasia
Mifepristone may be an effective alternative to adrenalectomy in patients with hypercortisolism caused by primary bilateral macronodular adrenal hyperplasia.
Transsphenoidal Surgery Recommended for Cushing Disease With Inconclusive or Normal MRI
In the absence of clear evidence of a pituitary adenoma on imaging, there is some controversy regarding the best treatment for Cushing disease.
High Prevalence of Diabetes in Patients With Primary Aldosteronism
Prevalence of diabetes is higher in patients with primary aldosteronism and was found to be related to suspected subclinical hypercortisolism.
Levoketoconazole Improves Biochemical and Clinical Parameters in Patients With Cushing Syndrome
Biochemical markers and clinical signs and symptoms of endogenous Cushing syndrome improved after 6 months of levoketoconazole therapy.
New Data for Potential Cushing Syndrome Treatment Levoketoconazole Announced
Researchers reported that mean urinary-free cortisol (mUFC) normalization with Recorlev was similar in patients with and without diabetes.
Cushing Syndrome in Pregnancy: When to Suspect and How to Treat
Despite the preponderance of CS in women of childbearing age and the likelihood of pregnancy triggering CS, the condition is often overlooked because of the overlap of pregnancy and hypercortisolism symptoms.
Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
Plasma levels of the orexigenic neuropeptide agouti-related protein (AgRP) are elevated in Cushing disease, and it may be a marker of hypothalamic AgRP.
Next post in Adrenal
